Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/17/2864333/0/en/Enterome-Announces-Successful-Completion-of-Phase-2-ROSALIE-Study-of-EO2401-in-Recurrent-Glioblastoma.html
https://www.globenewswire.com//news-release/2024/03/06/2841223/0/en/Enterome-Announces-Upcoming-Presentation-on-OncoMimics-Approach-to-Cancer-Immunotherapy-at-the-AACR-Annual-Meeting-2024.html
https://www.globenewswire.com//news-release/2023/12/18/2797609/0/en/Enterome-Appoints-Industry-Veteran-Dr-Peter-Hirth-to-its-Board-of-Directors.html
https://www.globenewswire.com/news-release/2023/11/20/2783045/0/en/Enterome-s-OncoMimics-Immunotherapy-EO2401-Significantly-Improves-Survival-Rate-in-Recurrent-Glioblastoma.html
https://www.globenewswire.com//news-release/2023/11/13/2778823/0/en/Enterome-to-Present-Updated-Data-From-Phase-1-2-ROSALIE-Trial-of-its-Peptide-Based-Immunotherapy-EO2401-in-Recurrent-Glioblastoma-at-SNO-2023.html
https://www.globenewswire.com//news-release/2023/11/01/2770955/0/en/Enterome-Presents-Immune-Monitoring-Data-on-EO2401-at-the-38th-Annual-Meeting-of-the-Society-for-Immunotherapy-of-Cancer-SITC.html
https://www.globenewswire.com//news-release/2023/10/30/2768969/0/en/Enterome-Selected-to-The-Leukemia-Lymphoma-Society-s-Therapy-Acceleration-Program.html
https://www.globenewswire.com//news-release/2023/10/25/2766533/0/en/Enterome-to-Present-Clinical-Progress-on-its-OncoMimics-Pipeline-at-Upcoming-Investor-Meetings.html
https://www.globenewswire.com//news-release/2023/10/23/2764674/0/en/Enterome-Presents-Positive-Data-from-Phase-1-2-SPENCER-Trial-of-EO2401-in-Adrenal-Tumors-at-ESMO-2023-Congress.html
https://www.globenewswire.com//news-release/2023/10/16/2760432/0/en/Enterome-to-Present-Data-on-EO2401-in-Adrenal-Tumors-at-the-European-Society-for-Medical-Oncology-ESMO-2023-Congress.html